MELD Score Predicts Survival in Patients Treated with Transjugular Intrahepatic Portosystemic Shunt after Liver Transplantation

• Published in: Transplantation Vol. 102 Suppl 7S-1; no. Supplement 7; p. S886
• Main Authors: Ibáñez-Samaniego, Luis, Catalina, María Vega, López, María, González, Manuel, Romero, Mario, Caballero, Aránzazu, López-Baena, José Ángel, Rincón, Diego, Echenagusía, Mikel, Bañares, Rafael, Salcedo, Magdalena
• Format: Journal Article
• Language: English
• Published: Copyright Wolters Kluwer Health, Inc. All rights reserved 01-07-2018
• ISSN: 0041-1337; 1534-6080
• DOI: 10.1097/01.tp.0000543976.41686.9a

INTRODUCTIONTransjugular intrahepatic portosystemic shunt (TIPS) is widely used to treat the complications of portal hypertension. Predictors of poor outcome have been described in patients with cirrhosis. However, in the setting of liver transplantation (LT) predictors of mortality are unknown, hence the limited use of TIPS in LT patients who develop portal hypertension. Therefore, the objective of the study was to identify survival predictors in LT patients treated with TIPS.
PATIENTS AND METHODSSingle-center, retrospective study that analysed demographic, hepatic, hemodynamic, cardiac and technical variables of LT patients treated with TIPS in a tertiary hospital. A Cox regression multivariate model was used to identify predictors of survival. Receiving operator characteristics (ROC) curve identified the most accurate cut-off points and Kaplan-Meier curves and Breslow test were used for the survival analysis. Data is presented as median and interquartilic range or percentage.
RESULTS AND DISCUSSIONTIPS was performed in 24 patients (2.1% of 1127 LT patients since 1990)17 males with a median age of 56 years (48-62). The main indications for TIPS were refractory ascites (75%), portal hypertensive bleeding (20.8%) and portal vein thrombosis (4.2%). The most frequent etiology of LT was hepatitis C related cirrhosis (75%). Time from LT to TIPS creation was 2.3 years (0.7-6.2). TIPS was successfully created in all patients. Immediate complications of the procedure were hepatic encephalopathy (87.5%grade III-IV33%), infections (66.7%) and heart failure (20.8%). Predictors of mortality (table 1) in the univariate model (p<0.10) were age (HR 1.06 [CI95% 0.990-1.145] p=0.092), AST (HR 1.01 [CI95% 1.001-1.019] p=0.027), alkaline phosphatase (HR 1.006 [CI95% 1.001-1.011] p=0.026) and MELD (HR 1.13 [CI95% 0.985-1.297] p=0.081). In the multivariate analysis only MELD remained as an independent predictor of mortality (HR 1.18 [CI95% 1.02-1.365] p=0.026). Area under ROC curve for MELD accuracy to predict mortality was 0.82 being a MELD score of 13 points the best cut-off (sensitivity 86%, specificity 71%). LT patients with a MELD score below 13 points at the time of TIPS creation presented a significantly better two-year survival (80.0% vs 61.9%; p=0.040. Figure 1).(Figure is included in full-text article.)(Figure is included in full-text article.)
CONCLUSIONPost-TIPS survival in LT patients is mainly related to liver function (MELD Score) at the time of the procedure. Patients with a MELD score above 13 points have a higher mortality after TIPS creation.